BMC Health Services Research, Journal Year: 2024, Volume and Issue: 24(1)
Published: Oct. 11, 2024
South Africa is composed of a two-tier healthcare system. One tier private system that funded through medical insurance, and comprised people who can afford to make monthly payments towards their insurance. Second government-funded public system, which covers the majority population. This study explored perceived barriers current strategies being utilised by pharmaceutical industry increase access innovator medicines. The objectives were to: (1) quantify classify medicines registered between 2010 2020 African Health Products Regulatory Authority (SAHPRA); (2) identify accessing in interviews with market managers from companies; (3) explore used industry. employed quantitative qualitative methodology. Whereby former involved extraction list regulator database, latter 9 semi structured interviews. Purposive sampling was conducted association member companies. included seven two medicine one payers Africa. Thematic analysis interpret data collected study. According database during review period, 238 registered. Only 14.77% available sector form tenders, whereas (based on products having SEP), 76.92% available. From six themes emerged: reimbursement medicines, types reimbursement, partnerships, technology, legislative challenges, other factors (e.g., real-world evidence). Access challenge, as price these therapies high. Therefore, various stakeholders health must collaborate implement solutions are locally relevant. government needs proactively update policies would allow for alternative methods be explored.
Language: Английский